Rankings
▼
Calendar
LAB Q2 2016 Earnings — Standard BioTools Inc. Revenue & Financial Results | Market Cap Arena
LAB
Standard BioTools Inc.
$370M
Q2 2016 Earnings
Healthcare
Medical - Devices
Income Statement
Revenue
$28M
Gross Profit
$16M
55.7% margin
Operating Income
-$18M
-64.4% margin
Net Income
-$19M
-66.1% margin
EPS (Diluted)
$-0.64
QoQ Revenue Growth
-2.9%
Cash Flow
Operating Cash Flow
-$7M
Free Cash Flow
-$9M
Stock-Based Comp.
$4M
Balance Sheet
Total Assets
$342M
Total Liabilities
$258M
Stockholders' Equity
$84M
Cash & Equivalents
$36M
Geographic Segments
UNITED STATES
$14M
49%
Europe
$8M
30%
Asia Pacific
$4M
14%
Other Geographical Countries
$2M
7%
← FY 2016
All Quarters
Q3 2016 →
